Histopathology of women with non-uniform endometrial echogenicity and risk factors for atypical endometrial hyperplasia and carcinoma

被引:6
|
作者
Cong, Qing [1 ,2 ,3 ]
Luo, Lingxiao [1 ,2 ,3 ]
Fu, Zhongpeng [1 ,2 ,3 ]
Lu, Jiaqi [1 ,2 ,3 ]
Jiang, Wei [1 ,2 ,3 ]
Sui, Long [1 ,2 ,3 ]
机构
[1] Fudan Univ, Obstet & Gynecol Hosp, Shanghai, Peoples R China
[2] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
[3] Shanghai Med Ctr Key Programs Female Reprod Dis, Shanghai, Peoples R China
来源
关键词
Non-uniform endometrium; echogenicity; hysteroscopy; histopathology; risk factors; atypical endometrial hyperplasia; endometrial carcinoma; endometrial lesions; CANCER; ULTRASOUND; THICKNESS; CURETTAGE; ACCURACY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: In sonography, homogeneous endometrium is defined as uniform endometrial echogenicity and heterogeneous, asymmetrical or cystic endometrium is defined as non-uniform. However, the relationship between the non-uniform endometrial echogenicity and the presence or absence of pathology is not known. A retrospective study of the patients with ultrasound non-uniform endometrium who underwent hysteroscopy-directed biopsy was performed to explore its clinical meaning in the diagnosis of endometrial lesions. Materials and methods: Patients with non-uniform endometrial echogenicity who underwent hysteroscopy-directed biopsy were enrolled in the Obstetrics and Gynecology Hospital of Fudan University from January 2015 to May 2018 as the primary cohort. In total, 692 patients with non-uniform endometrial echogenicity were diagnosed and underwent hysteroscopy-directed biopsy. Characteristics were assessed using univariate logistic regression between patients with and without atypical endometrial hyperplasia and carcinoma (atypical EH+). Multivariate analyses were used to develop the predicting model. We incorporated statistically significant variables and presented with nomogram. Internal validation was assessed. An independent validation cohort consisted of 237 consecutive patients from June 2018 to February 2019. Results: Hysteroscopy-directed biopsy showed that 55.20% (382/692) of the patients with non-uniform endometrium had normal endometrium, while 44.80% (310/692) had endometrial lesions, including 39.31% (272/692) benign lesions and 5.49% (38/692) atypical EH+. Univariate logistic analysis showed that older age (P=0.027), abnormal uterine bleeding (AUB) before menopause (P=0.011), postmenopausal bleeding (P<0.001) and endometrial thickness >= 7 mm (P=0.013) were statistically significant for atypical EH+. Multivariate logistic regression analysis showed that age >= 50 years old (OR: 3.97, 95% CI: 1.17-13.43, P=0.027), endometrial thickness >= 7 mm (OR: 8.08, 95% CI: 1.86-35.08, P=0.005) and postmenopausal bleeding (OR: 8.98, 95% CI: 3.26-24.76, P<0.001) were risk factors for atypical EH+. Predictors in the individualized predicted nomogram included age >= 50 years old, AUB before menopause, postmenopausal bleeding and endometrial thickness >= 7 mm. The model showed good discrimination with area under curve (AUC) of 77.09%. With cutoff value of 0.0089267, the recall of atypical EH+ is 100% with precision 6.52% and 6.22% in both primary and validation cohort, respectively. Conclusion Non-uniform endometrial echogenicity is clinically meaningful in assessment of atypical EH+ with risk factors of age >= 50 years old, postmenopausal bleeding and endometrial thickness >= 7 mm. The model can help clinician to predicate the probability of atypical EH+ and make clinical decision.
引用
收藏
页码:4500 / 4509
页数:10
相关论文
共 50 条
  • [1] ENDOMETRIAL HYPERPLASIA AND CARCINOMA - HISTOPATHOLOGY AND HORMONAL FACTORS
    BJERSING, L
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1977, : 83 - 88
  • [2] RISK OF ENDOMETRIAL CARCINOMA AFTER THE DIAGNOSIS OF ATYPICAL ENDOMETRIAL HYPERPLASIA
    Prat, J.
    Szafranska, J.
    D'Angelo, E.
    Serrat, N.
    Barbareschi, M.
    Espinosa, I.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 247 - 247
  • [3] Risk of occult atypical hyperplasia or cancer in women with non-atypical endometrial hyperplasia
    Lee, N.
    Lee, K. B.
    Kim, K.
    Hong, J. H.
    Yim, G. W.
    Seong, S. J.
    Lee, B.
    Lee, J. M.
    Lim, S.
    Ouh, Y. T.
    Kim, Y. B.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 217 - 217
  • [4] Histopathology of endometrial hyperplasia and endometrial carcinoma An update
    Horn, Lars-Christian
    Meinel, Alexandra
    Handzel, Romy
    Einenkel, Jens
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2007, 11 (04) : 297 - 311
  • [5] Concurrent endometrial carcinoma in Chinese women with a preoperative diagnosis of atypical endometrial hyperplasia
    Chang, Y.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 99 - 100
  • [6] IMMUNOCYTODIAGNOSIS OF ATYPICAL HYPERPLASIA AND ENDOMETRIAL CARCINOMA IN POSTMENOPAUSAL WOMEN
    MOTTOLESE, M
    VOCATURO, A
    BARTOLAZZI, A
    VOCATURO, G
    BENEVOLO, M
    SEDATI, A
    ATLANTE, G
    PRAT, M
    BIGOTTI, A
    NATALI, PG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (06) : 869 - 872
  • [7] Factors Predictive of Endometrial Carcinoma in Patients with Atypical Endometrial Hyperplasia on Preoperative Histology
    Touboul, Cyril
    Piel, Bruno
    Koskas, Martin
    Gonthier, Clementine
    Ballester, Marcos
    Cortez, Annie
    Darai, Emile
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 5670 - 5676
  • [8] Preoperative Factors of Endometrial Carcinoma in Patients Undergoing Hysterectomy for Atypical Endometrial Hyperplasia
    Burrows, Adelaide
    Pudwell, Jessica
    Bougie, Olga
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (07) : 822 - 830
  • [9] The incidence of endometrial carcinoma in patients with atypical endometrial hyperplasia versus atypical endometrial polyp
    Laskov, Ido
    Tzur, Yossi
    Zindel, Ofra
    Michaan, Nadav
    Tako, Einat
    Aizic, Asaf
    Grisaru, Dan
    Cohen, Aviad
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S220 - S220
  • [10] Associations between incident endometrial hyperplasia and risk factors for endometrial carcinoma
    Chia, Victoria
    Rush, Brenda
    Langholz, Bryan
    Richesson, Douglas
    Sherman, Mark
    Glass, Andrew
    Ronnett, Brigitte
    Ioffe, Olga
    Chatterjee, Nilanjan
    Lacey, James
    [J]. CANCER RESEARCH, 2008, 68 (09)